It's been almost a year since the FDA slammed the door on approving MDMA, more commonly known as ecstasy, as a treatment for PTSD.

It was a big setback for advocates of psychedelic-assisted therapy who believe it can help treat depression or drug addiction when administered safely.

But it's been six months since President Donald Trump returned to the White House,

and some in the psychedelic community are feeling optimistic,

especially with Robert F. Kennedy Jr. in charge of health and human services.

Marty McHaree has told me that we don't want to wait two years to get this done.

These are people who badly need some kind of therapy.

Nothing else is working for them.

Kennedy and McCarrie, his FDA chief, have promised to prioritize psychedelics and fast-track review times.

What's more, Deep Red Texas is pouring millions of taxpayer dollars into researching

a powerful drug called Ibogaine. Podcasters like Theo Vaughn and Joe Rogan have even expressed

interest. We should be paying attention to the people that report great benefits. Like,

there's just too many. Now, this push to get Washington to pay attention to mind-altering substances isn't new.

Government research for therapeutic use of psilocybin and LSD goes back to the 1960s.

But some believe who is showing support now may be.

So, is this moment actually different for psychedelics?

And will the backing from Trump world hurt or help?

Today, in part one of a two-part series,

I'm going to talk to an army veteran who says psychedelics helped her get off drugs for good.

From CNN, this is one thing.

I'm David Rind.

We're back in a bit. Hi, this is Ava from Vanta.

...